IMPORTANCE Increased rates of autoimmune conditions have been reported in association with systemic lupus erythematosus (SLE). Little is known about coexisting autoimmune conditions in patients with cutaneous lupus erythematosus (CLE) without SLE.
C utaneous lupus erythematosus (CLE) is characterized by a variety of photosensitive skin f i n d i n g s t h a t a p p e a r i n t h e p r e s e n c e o r absence of systemic lupus erythematosus (SLE). Both CLE and SLE are autoimmune disorders as defined by the modified Witebsky postulates. 1 Among patients with SLE, 6% to 30% have a coexisting autoimmune condition, including Sjögren syndrome, autoimmune thyroid d i s e a s e , r h e u m at o i d a r t h r it i s ( R A ) , a n d i m m u n e thrombocytopenia. 2, 3 Because little is known about autoimmune diseases in patients who have CLE without concurrent SLE (CLE-only), we investigated the prevalence and risk factors of hav ing coexisting autoimmune conditions in patients with CLE-only.
Methods
A cross-sectional study was conducted among patients with CLE. 
Results
Of the 285 patients initially screened, 129 patients with CLE-only were included. Twenty-three (17.8%) patients with CLE-only had at least 1 coexisting autoimmune condition ( Multivariable analyses showed that white race was more frequently present in CLE-only patients with at least 1 coexisting autoimmune condition(s) (odds ratio [OR], 2.88; 95% CI, 1.00-8.29; P = .0498). Additionally, CLE-only patients who never smoked (OR, 3.28; 95% CI, 1.14-9.39; P = .03), had positive family history for autoimmunity (OR, 3.54; 95% CI, 1.21-10.39; P = .02), and had positive ANA test results (OR, 4.87; 95% CI, 1.69-14.03; P = .003) were more likely to have 1 or more coexisting autoimmune condition(s) ( Table 3) .
Discussion
A total of 17.8% of our CLE-only patients had at least 1 coexisting autoimmune condition, a rate almost 4-fold higher than the general population (4.5%) 1 and similar to that reported for patients with SLE. 2, 3 Moreover, for patients with CLE, meeting 1 to 3 SLE American College of Rheumatology criteria may not increase the risk of coexisting autoimmune conditions vs meeting 4 or more criteria. Patients with autoimmune conditions are susceptible to developing others, likely due to commonly shared genetic abnormalities. Several genetic polymorphisms have been found in multiple autoimmune diseases including genes for protein tyrosine phosphatase nonreceptor type 22 (PTPN22), tumor necrosis factor-induced protein 3 (TNFAIP3), signal transducer and activator of transcription 4 (STAT4), and cytotoxic T-lymphocyte-associated protein 4 (CTLA4). 4 Autoimmune thyroid disease including Graves disease and Hashimoto thyroiditis was the most commonly reported autoimmune condition. This rate could be higher because we excluded 9 cases of hypothyroidism due to inadequate documentation. We recommend checking for symptoms, physical examination findings, and laboratory test abnormalities associated with thyroid disease in patients with CLE, especially those with systemic complaints such as fatigue that may mimic SLE. Sjögren syndrome and RA were 2 other common autoimmune diseases. McDonagh and Isenberg 2 identified that 6% of patients with SLE had concomitant RA. Sjögren syndrome has been reported in 9% to 13% of patients with lupus. 2, 5 While arthritis is the most common symptom in patients with SLE, our data illustrate that arthritis in CLE-only patients may be due to other disease processes such as RA. Referrals to rheumatologists will be helpful to pinpoint arthritis diagnoses. Patients with Sjögren syndrome and those with subacute CLE commonly share circulating anti-Sjögren syndrome-related antigen A antibodies, which likely explains the increase in Sjögren disease prevalence in our cohort. All 4 CLE-only patients with Sjögren syndrome had predominantly subacute CLE. Thus, asking CLE-only patients for presence of sicca-like symptoms can prompt further evaluation and workup. White patients with CLE-only were more likely to have coexisting autoimmune conditions compared with nonwhites. This could be due to the predisposition for whites to develop some of the most common autoimmune conditions, including Sjögren syndrome, Hashimoto thyroiditis, and morphea. 1, [6] [7] [8] The nonsmoking history associated with increased likelihood of coexisting autoimmune diseases in our CLE-only cohort contradicts previous epidemiologic studies linking smoking with development of several autoimmune conditions. 9 However, studies have reported protective effects of smoking in autoimmune diseases such as ulcerative colitis and autoimmune diabetes. 9,10 Antiinflammatory effects of nicotine in vivo have been proposed as a mechanism for its protective effects. 11 Larger studies are necessary to verify these associations. A history of positive ANA test result was another risk factor for CLE-only patients having a coexisting autoimmune condition. Having a positive ANA test result indicates a predisposition to autoimmunity but is nonspecific for diagnosis of many autoimmune diseases.
12 This is illustrated by the sensitivities of positive ANA test results in autoimmune thyroid disease (20%-70%), RA (41%), Sjögren syndrome (48%), and SLE (93%).
13
Family history of autoimmunity was another significant risk factor. The most common autoimmune conditions of CLE family members included SLE, Hashimoto thyroiditis, and RA, which is similarly found in patients with other autoimmune diseases.
14 Shared genetic polymorphisms are likely responsible for these findings. Of note, 8 participants progressed from CLE-only to SLE, with a median time frame of 4.3 years. One had 1 or more coexisting autoimmune condition(s) and had subacute CLE. Three had histories of positive ANA test results at their initial visits.
Limitations
This study was limited by small sample size, missing data due to unavailable medical records from other facilities, and crosssectional design. Nonetheless, our CLE cohort is predominantly female, consistent with prior studies, 15 and racially diverse, which should make it generalizable to larger populations. To confirm our findings, we are planning larger longitudinal studies.
Conclusions
This study showed that CLE-only patients are at increased risk for coexisting autoimmune condition(s). Those CLEonly patients with white race, nonsmoking history, positive ANA test results, and positive family history of autoimmunity were more likely to have additional autoimmune disorders. We recommend that clinicians collect a thorough history and review of systems and perform appropriate screenings for autoimmune disorders in patients with CLE. Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
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